ALRN - Aileron Therapeutics Inc
IEX Last Trade
2.52
0.170 6.746%
Share volume: 10,919
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.35
0.17
7.23%
Summary score
10%
Profitability
0%
Dept financing
9%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.98%
Return on assets
-22.65%
Return on sales
0%
Return on invested capital
-149.29%
Total debt ratio
28.81%
Debt ratio change over timeo
-1.02%
Current Ratio
5.43%
Quick Ratio
0%
Cash Position Ratio
1.97%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-43.62%
Return on assets
-25.01%
Return on sales
0%
Return on invested capital
-637.33%
Total debt ratio
41.01%
Debt ratio change over timeo
-1.1%
Current Ratio
3.42%
Quick Ratio
0%
Cash Position Ratio
1.8%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-26.36%
Return on assets
-16.84%
Return on sales
0%
Return on invested capital
-287.12%
Total debt ratio
36.25%
Debt ratio change over time
-1.03%
Current Ratio
3.99%
Quick Ratio
0%
Cash Position Ratio
3.48%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.08%
Return on assets
-99.79%
Return on sales
0%
Return on invested capital
37.43%
Total debt ratio
-102.36%
Debt ratio change over time
-1.02%
Current Ratio
0.09%
Quick Ratio
0%
Cash Position Ratio
-0.87%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -33.98% | -3.05% | 11.55% | 6.27% |
| Return on assets | -22.65% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -149.29% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 28.81% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.02% | 6.09% | 6.03% | 1.53% |
| Dept financing | 7% | 50% | 43% | 14% |
| Current Ratio | 3.42% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.8% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 49% | 56% |
| Short-term ratios | ALRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -43.62% | -25.62% | 17.94% | 7.14% |
| Return on assets | -25.01% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -637.33% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 41.01% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.1% | -23.44% | 9.66% | 0.6% |
| Dept financing | 10% | 25% | 45% | 8% |
| Current Ratio | 3.42% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.8% | 1.48% | 0.76% | 1.49% |
| Liquididy | 49% | 53% | 40% | 71% |